The Lobesity Research Laboratories in Cleveland Ohio
Obesity Co-Founder and Chief Medical Officer M Michael Wolfe, MD is joined by Chief Executive Officer Stephen A. Charles, PhD and Co-Founder and Chief Scientific Officer Michael O. Boylan, PhD at the Lobesity Research Lab. Lobesity is a break-through treatment for obesity that utilizes a proprietary anti-GIP Monoclonal Antibody to target obesity at its roots.